| Literature DB >> 26602880 |
Pierre Delanaye1, Martin Flamant2, Étienne Cavalier3, Fabrice Guerber4, Thomas Vallotton5, Olivier Moranne6, Hans Pottel7, Jean-Jacques Boffa8, Christophe Mariat9.
Abstract
While the CKD-EPI (for Chronic Kidney Disease Epidemiology) equation is now implemented worldwide, utilization of the Cockcroft formula is still advocated by some physicians for drug dosage adjustment. Justifications for this recommendation are that the Cockcroft formula was preferentially used to determine dose adjustments according to renal function during the development of many drugs, better predicts drugs-related adverse events and decreases the risk of drug overexposure in the elderly. In this opinion paper, we discuss the weaknesses of the rationale supporting the Cockcroft formula and endorse the French HAS (Haute Autorité de santé) recommendation regarding the preferential use of the CKD-EPI equation. When glomerular filtration rate (GFR) is estimated in order to adjust drug dosage, the CKD-EPI value should be re-expressed for the individual body surface area (BSA). Given the difficulty to accurately estimate GFR in the elderly and in individuals with extra-normal BSA, we recommend to prescribe in priority monitorable drugs in those populations or to determine their "true" GFR using a direct measurement method.Entities:
Keywords: Adaptation posologique; CKD-EPI; Cockcroft; Dosage adjustment
Mesh:
Year: 2015 PMID: 26602880 DOI: 10.1016/j.nephro.2015.07.472
Source DB: PubMed Journal: Nephrol Ther ISSN: 1769-7255 Impact factor: 0.722